Federal award
CMC PHARMACEUTICALS, INC.
W911QY18C0198
ContractSBIR/STTR SR1
Obligated and Ceiling
- Obligated (net)
- $149,268.80
- Ceiling (potential value, not spending)
- $149,268.80
- Current value
- $149,268.80
- Gross positive obligations
- $149,268.80
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- CMC PHARMACEUTICALS, INC. · R9AVS7XL2YB4
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- CMC PHARMACEUTICALS, INC. · R9AVS7XL2YB4
- Awarding agency
- Department of War · sub-agency 2100 · office W911QY
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AN71 · R&D-SPEC MED SVCS-B RES
- Industry (NAICS)
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- PIID
- W911QY18C0198
- Award type code
- D
- Actions
- 1 · Sep 27, 2018 to Sep 27, 2018
- Why it is listed
- gross positive obligations of $100k or more (contracts); SBIR/STTR award
Action History1
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 27, 2018 | FY2018 | 0 | — | $149,268.80 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.